Skip to main content

Advertisement

SpringerLink
Log in

Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

The primary antipsychotic-induced creatine kinase elevation (i.e., not due to neuroleptic malignant syndrome, extrapyramidal symptoms, etc.) is a poorly studied condition.

Objectives

The aims of the present study were to provide an overview of published cases with antipsychotic-induced creatine kinase elevation and give recommendations for the clinical practice.

Methods

PubMed and EMBASE were searched for eligible trials, case series, and case reports. We set a threshold at ten times the upper normal limit of the creatine kinase value in order to define an elevation as significant.

Results

The prevalence of significant creatine kinase elevation ranged between 2 and 7 %. We found a total of 42 eligible cases. Men were overrepresented in our sample (81 %). Patients with myoglobinuria were more likely to be symptomatic (Fisher’s exact test, p = 0.006), whereas neither myoglobinuria (Mann-Whitney test, p > 0.10) nor symptoms (Mann-Whitney test, p = 0.64) were related to the magnitude of the creatine kinase (CK) elevation. In the majority of the cases, the antipsychotic medication was discontinued (86 %). Forced diuresis was given in 36 % of the patients. Eighty-three percent of the patients had no further complications. Only one case was found with a de novo acute renal failure.

Conclusions

The discontinuation of the antipsychotic medication was a sufficient measure for the CK elevation to subside in the majority of the cases. Cases with myoglobinuria should eventually be treated more aggressively. Further recommendations for the clinical practice are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adityanjee (1991) The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome. Br J Psychiatry 158:706–707

    Article  PubMed  CAS  Google Scholar 

  • Agarkar S (2011) Elevated creatine kinase levels with second-generation antipsychotics. J Neuropsychiatry Clin Neurosci 23(3):E49–E50. doi:10.1176/appi.neuropsych.23.3.E49

    Article  PubMed  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington DC

    Google Scholar 

  • Apikoglu Rabus S, Izzettin F, Rabus M, Bilici M (2006) Severe creatine kinase increase during quetiapine and mirtazapine treatment. Psychopharmacology (Berl) 185(2):263–264

    Article  CAS  Google Scholar 

  • Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S (2010) Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (11):CD006633. doi:10.1002/14651858.CD006633.pub2

  • Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S (2013) Quetiapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 11:CD006625. doi:10.1002/14651858.CD006625.pub3

    PubMed  Google Scholar 

  • Baumgart U, Schmid R, Spiessl H (2005) Olanzapine-induced acute rhabdomyolysis—a case report. Pharmacopsychiatry 38(1):36–37

    Article  PubMed  CAS  Google Scholar 

  • Boot E, de Haan L (2000) Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine. Psychopharmacology (Berl) 150(3):347–348

    Article  CAS  Google Scholar 

  • Cavanaugh JJ, Finlayson RE (1984) Rhabdomyolysis due to acute dystonic reaction to antipsychotic drugs. J Clin Psychiatry 45(8):356–357

    PubMed  CAS  Google Scholar 

  • Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD (2008) The syndrome of rhabdomyolysis: complications and treatment. Eur J Intern Med 19:568–574

    Article  PubMed  Google Scholar 

  • Conley RR, Meltzer HY (2000) Adverse events related to olanzapine. J Clin Psychiatry 61(Suppl 8):26–29

    PubMed  CAS  Google Scholar 

  • Correll CU (2007) Acute and long-term adverse effects of antipsychotics. CNS Spectr 12(12 Suppl 21):10–14

    PubMed  Google Scholar 

  • De Hert M, Kalnicka D, van Winkel R, Wampers M, Hanssens L, van Eyck D, Scheen A, Peuschkens J (2006) Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 67:1889–1896

    Article  PubMed  Google Scholar 

  • Deravajan S, Dursun SM (2000) Antipsychotic drugs, serum creatine kinase (CPK) and possible mechanisms. Psychopharmacology (Berl) 152:122

    Article  Google Scholar 

  • Flanagan RJ (2008) Side effects of clozapine and some other psychoactive drugs. Curr Drug Saf 3(2):115–122

    Article  PubMed  CAS  Google Scholar 

  • Giannoglou GD, Chatzizisis YS, Misirli G (2007) The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Int Med 18:90–100

    Article  CAS  Google Scholar 

  • Giner V, Muñoz R, Redón J (2002) Risperidone severe cerivastatin-induced rhabdomyolysis. J Intern Med 251(2):177–178

    Article  PubMed  CAS  Google Scholar 

  • Harper CR, Jacobson TA (2007) The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol 18:401–408

    Article  PubMed  CAS  Google Scholar 

  • Himmerich H, Ehrlinger M, Hackenberg M, Löhr B, Nickel T (2006) Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine. J Clin Psychopharmacol 26(6):676–677

    Article  PubMed  Google Scholar 

  • Hoshi S, Itoh A, Kato S, Suzuki K, Kawamura S, Orikasa S (1999) Severe rhabdomyolysis as a complication of high-dose chemotherapy in a patient with advanced testicular cancer. Int J Urol 6(1):56–58

    Article  PubMed  CAS  Google Scholar 

  • Karre PR, Gujral J, Rodriguez E (2009) Rhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate. BMJ Case Rep. doi:10.1136/bcr.06.2009.1931

    PubMed  PubMed Central  Google Scholar 

  • Keshavan MS, Stecker J, Kambhampati RK (1994) Creatine kinase elevations with clozapine. Br J Psychiatry 164(1):118–120

    Article  PubMed  CAS  Google Scholar 

  • Kirson JI, McQuistion HL, Pierce DW (1995) Severe elevations in serum creatine kinase associated with clozapine. J Clin Psychopharmacol 15(4):287–288

    Article  PubMed  CAS  Google Scholar 

  • Klein JP, Fiedler U, Appel H, Quante A, Jockers-Scherübl MC (2006) Massive creatine kinase elevations with quetiapine: report of two cases. Pharmacopsychiatry 39(1):39–40

    Article  PubMed  CAS  Google Scholar 

  • Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S (2010) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. doi:10.1002/14651858.CD006654.pub2

    Google Scholar 

  • Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S (2011) Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. doi:10.1002/14651858.CD006626.pub2

    PubMed  PubMed Central  Google Scholar 

  • Koren W, Koren E, Nacasch N, Ehrenfeld M, Gur H (1998) Rhabdomyolysis associated with clozapine treatment in a patient with decreased calcium dependent potassium permeability of cell membranes. Clin Neuropharmacol 21(4):262–264

    PubMed  CAS  Google Scholar 

  • Lazarus AL, Toglia JU (1985) Fatal myoglobinuric renal failure in a patient with tardive dyskinesia. Neurology 35(7):1055–1057

    Article  PubMed  CAS  Google Scholar 

  • Marcus EL, Vass A, Zislin J (1999) Marked elevation of serum creatine kinase associated with olanzapine therapy. Ann Pharmacother 33(6):697–700

    Article  PubMed  CAS  Google Scholar 

  • Marinella MA (1997) Rhabdomyolysis associated with haloperidol without evidence of NMS. Ann Pharmacother 31(7–8):927–928

    PubMed  CAS  Google Scholar 

  • Marsh SJ, Dolson GM (1995) Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy. Ren Fail 17(4):475–478

    Article  PubMed  CAS  Google Scholar 

  • Martí-Bonmatí E, San Valero-Carcelén E, Ortega-García MP, Rubini-Puig R (2003) Olanzapine elevation of serum creatine kinase. J Clin Psychiatry 64(4):483–484

    Article  PubMed  Google Scholar 

  • Martin PD, Warwick MJ, Dane AL, Hill SJ, Giles PB, Phillips PJ, Lenz E (2003) Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers. Clin Ther 25(11):2822–2835

    Article  PubMed  CAS  Google Scholar 

  • Marzetti E, Bocchino L, Teramo S, Scudieri G, Aulisa AG (2012) Rhabdomyolysis in a patient on aripiprazole with traumatic hip prosthesis luxation. J Neuropsychiatry Clin Neurosci 24(4):E40–E41. doi:10.1176/appi.neuropsych.11110328

    Article  PubMed  CAS  Google Scholar 

  • McMahon GM, Zeng X, Walkar SS (2013) A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. doi:10.1001/jamainternmed.2013.9774

    PubMed  Google Scholar 

  • Meltzer HY (1968) Creatine kinase and aldolase in serum: abnormality common to acute psychoses. Science 159:1368–1370

    Article  PubMed  CAS  Google Scholar 

  • Meltzer HY (1969) Muscle enzyme release in the acute psychoses. Arch Gen Psychiatry 21:102–112

    Article  PubMed  CAS  Google Scholar 

  • Meltzer HY (2000) Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message? Psychopharmacology (Berl) 150(3):349–350

    Article  CAS  Google Scholar 

  • Meltzer HY, Cola PA, Parsa M (1996) Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacology 15(4):395–405

    Article  PubMed  CAS  Google Scholar 

  • Mohr WK, Petti TA, Mohr BD (2003) Adverse effects associated with physical restraint. Can J Psychiatry 48(5):330–337

    PubMed  Google Scholar 

  • Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reaction. Clin Pharm Ther 30(2):239–245

    Article  CAS  Google Scholar 

  • Oulis P, Koulouris GC, Konstantakopoulos G, Masdrakis VG (2007) Marked elevation of creatine kinase with sertindole: a case report. Pharmacopsychiatry 40(6):295–296

    Article  PubMed  CAS  Google Scholar 

  • Pearlman C, Wheadon D, Epstein S (1988) Creatine kinase elevation after neuroleptic treatment. Am J Psychiatry 145(8):1018–1019

    PubMed  CAS  Google Scholar 

  • Perlov E, Tebartz van Elst L, Czygan M, Bubl E, Ebert D (2005) Serum creatine kinase elevation as a possible complication of therapy with olanzapine. Naunyn Schmiedebergs Arch Pharmacol 372(2):168–169

    Article  PubMed  CAS  Google Scholar 

  • Punukollu B, Rutherford H (2008) Serum creatine kinase elevation associated with olanzapine treatment. BMJ Case Rep. doi:10.1136/bcr.06.2008.0040

    PubMed  PubMed Central  Google Scholar 

  • Reznik I, Volchek L, Mester R, Kotler M, Sarova-Pinhas I, Spivak B, Weizman A (2000) Myotoxicity and neurotoxicity during clozapine treatment. Clin Neuropharmacol 23(5):276–280

    Article  PubMed  CAS  Google Scholar 

  • Robert F, Koenig M, Robert A, Boyer S, Cathébras P, Camdessanché JP (2010) Acute camptocormia induced by olanzapine: a case report. J Med Case Rep 25(4):192. doi:10.1186/1752-1947-4-192

    Article  Google Scholar 

  • Scelsa SN, Simpson DM, McQuistion HL, Fineman A, Ault K, Reichler B (1996) Clozapine induced myotoxicity in patients with chronic psychotic disorders. Neurology 47:1518–1523

    Article  PubMed  CAS  Google Scholar 

  • Scharman EJ, Troutman WG (2013) Prevention of kidney injury following rhabdomyolysis: a systematic review. Ann Pharmacother 47(1):90–105. doi:10.1345/aph.1R215

    Article  PubMed  Google Scholar 

  • Schennach-Wolff R, Stübner S, Riedel M, Müller N (2010) Extensive elevation of creatine kinase with generic clozapine, but not with Leponex. Psychiatry Res. 30;176(1):93. doi:10.1016/j.psychres.2009.03.014

  • Shuster J (2000) Olanzapine and rhabdomyolysis. Nursing 30(9):87

    Article  PubMed  CAS  Google Scholar 

  • Terao T, Matsuda S, Kojima H, Okuno K, Hori H, Kaku A, Ueda N, Etoh A (1999) Incidence and risk factors of benign creatine phosphokinase elevations in chronic psychiatric patients. Neuropsychobiology 39(4):173–180

    Article  PubMed  CAS  Google Scholar 

  • Thase ME, Shostak M (1984) Rhabdomyolysis complicating rapid intramuscular neuroleptization. J Clin Psychopharmacol 4(1):46–48

    Article  PubMed  CAS  Google Scholar 

  • Thompson PD, Zmuda JM, Domalik LJ, Zimet RJ, Staggers J, Guyton JR (1997) Lovastatin increases exercise-induced skeletal muscle injury. Metabolism 46(10):1206–1210

    Article  PubMed  CAS  Google Scholar 

  • Tseng KC, Hwang TJ (2009) Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium. J Clin Psychopharmacol 29(4):398–399. doi:10.1097/JCP.0b013e3181accfc3

    Article  PubMed  Google Scholar 

  • Ursini F, Succurro E, Grembiale A, Arturi F (2010) Acute rhabdomyolysis during treatment with amisulpride and metformin. Eur J Clin Pharmacol 66(3):321–322. doi:10.1007/s00228-009-0773-x

    Article  PubMed  Google Scholar 

  • Velasco-Montes J, Oriñuela-González I, Sanjuán-López AZ (2012) Rhabdomyolysis secondary to quetiapine. Actas Esp Psiquiatr 40(2):97–99

    PubMed  Google Scholar 

  • Webber MA, Mahmud W, Lightfoot JD, Shekhar A (2004) Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin. J Psychopharmacol 18(3):432–434

    Article  PubMed  Google Scholar 

  • Wirshing DA (2001) Adverse effects of atypical antipsychotics. J Clin Psychiatry 62(Suppl 21):7–10

    PubMed  CAS  Google Scholar 

  • Wu YF, Chang KY (2011) Aripiprazole-associated rhabdomyolysis in a patient with schizophrenia. J Neuropsychiatry Clin Neurosci 23(3):E51. doi:10.1176/appi.neuropsych.23.3.E51

    Article  PubMed  Google Scholar 

  • Zink M, Knopf U, Argiriou S, Kuwilsky A (2006) A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone. J Clin Psychiatry 67(5):835

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

None.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, Medical Faculty of the Heinrich Heine University, Bergische Landstrasse 2, 40629, Düsseldorf, Germany

    Zacharias G. Laoutidis

  2. Eginition Hospital, 1st Department of Psychiatry, Medical Faculty, University of Athens, Vasilissis Sofias Avenue 72-74, 11528, Athens, Greece

    Kanellos T. Kioulos

Authors
  1. Zacharias G. Laoutidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kanellos T. Kioulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zacharias G. Laoutidis.

Appendix

Appendix

Table 6 For the data extraction the following format was used
Full size table

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laoutidis, Z.G., Kioulos, K.T. Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice. Psychopharmacology 231, 4255–4270 (2014). https://doi.org/10.1007/s00213-014-3764-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-014-3764-2

Keywords

Search

Navigation